Sanofi, GSK expect further price pressure, more M&A under Trump

LONDON (Reuters) - Two of Europe's biggest drugmakers warned on Tuesday there would be no let up in pressure on U.S. medicine prices after last week's presidential election win for Republican Donald Trump, which sent pharmaceutical and biotech shares soaring.

Sanofi, GSK expect further price pressure, more M&A under Trump
Read More


Bagikan Berita Ini